Roxane Laboratories Archives - CDR

Hikma to buy Roxane for $2.65 billion

July 31, 2015 by Chain Drug Review Andreas Barner, Boehringer Ingelheim, generic pharmaceuticals, Hikma Pharmaceuticals, Michael Raya, Roxane Laboratories, Said Darwazah, U.S. generic drug market, West-Ward Pharmacy, Supplier News

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane

Roxane rolls out Lotronex generic

May 28, 2015 by Chain Drug Review and Chain Drug Review alosetron hydrochloride tablets, irritable bowel syndrome, Lotronex generic, Roxane Laboratories Supplier News

COLUMBUS, Ohio — Roxane Laboratories Inc. has released alosetron hydrochloride tablets, a treatement for irritable bowel syndrome in women. The company said the tablets, available in 0.5-mg and 1-mg strengths in 30-count bottles, has begun shipping to wholesalers and pharmacies nationwide. According to Roxane, the Food and Drug Administration approved the Abbreviated New Drug Application